vitro effect of aldosterone on intracellular sodium, potassium and calcium concentrations and cell volume was shown in human mononuclear leukocytes. In the absence of aldosterone, the intracellular Na+, K+ and Ca2+ concentrations and the cell volume decreased significantly, but remained constant when aldosterone (1.4 nmol/l) was added to the incubation medium. These effects of aldosterone were blocked by the aldosterone antagonist canrenone (140 nmol/l). The sodium/proton exchanger of the cell membrane could be identified as the primary target of the aldosterone action, possibly non-genomically mediated through membrane receptors. The (1) , mammary gland (2) , arterial smooth muscle cells (3) and, recently, human mo¬ nonuclear leukocytes (HML, 4) . The demonstra¬ tion of mineralocorticoid receptors in these tissues has been performed by classic binding studies of radiolabelled compounds. Recently, Arriza et al. (5) cloned the mineralocorticoid receptor and demon¬ strated its mRNA in various tissues such as the hip¬ pocampus, kidney, heart, spleen, and pituitary gland. Data (6) . Though yet unknown in detail, this effector mechanism seems to involve the binding of aldosterone to a cytoplasmic receptor protein (7) inducing the nuclear pro¬ duction of mRNA. From this mRNA a specific pro¬ tein is translated (8) which is thought to create "new" sodium channels in the cell membrane (9) . This protein facilitates the passive entrance of sodium into the cells and the intracellular concenMedizinische Klinik Innenstadt, University ofMunich, FRG tration of sodium is increased. As a second step, the increased intracellular sodium concentration acti¬ vates and/or induces the production of Na-K-ATPase (10) . Owing to the polarity of the membrane distribution of Na-K-ATPase in tubular cells with a high concentration at the basal membrane, a transcellular transport of sodium and potassium is typ¬ ical for these cells (11) . The (24) .
On the other hand, a selective destruction of the AV3V region in the rat brain blocks the develop¬ ment of a DOCA-induced hypertension (25, 26) .
Though not known in detail, the mechanism of this intervention seems to involve the central angiotensin-pressor-mechanism and changes in the secre¬ tion of neurohumoral factors such as vasopressin and the endogenous Na-K-ATPase-inhibitor. (27 (30) . This cation transport is coupled with a hydrogencarbonate-chloride ex-change to balance the intracellular alkalinization, thus sodium chloride enters the cell during RVI (31) (32) (33) . This gain of sodium is paralleled by an increase in intracellular potassium by an activation of Na-K-ATPase (30) . For the RVI, the concordant increase in both intracellular sodium and potas¬ sium has been observed in consequence of a pri¬ mary increase in sodium influx and a secondary activation of Na-K-ATPase. The same holds true for the RVI in amphiuma red blood cells which also involves an activation of both the sodium-proton exchanger and Na-K-ATPase, resulting in a con¬ cordant increase in both sodium and potassium (34, 35) . Activation of both the sodium-proton ex¬ changer and the CI~-HC03 exchanger has also been shown for epithelial cells of the necturus gall bladder after osmotic shrinkage (36) and for the basolateral membrane of the Henle loop in the mouse (37).
In Fig. 1 In early studies, the induction of an apical increase in the sodium conductance of the tubular cell by a hypothetical "permease" was assumed. Electrophysiological methods demonstrated a short-circuit current which was inhibited by amiloride (10, 44) .
The increased entrance of sodium into the renal cells resulted in a rise of the intracellular sodium concentration (45) (46) (47) (48) . activates Na-K-ATPase and results in a concordant increase in the intracellular potassium concentration (b). This parallel increase in sodium and potassium is accompanied by transmembrane shifts of water and thus changes of cell volume (c). Via the Na/Ca exchanger the free intracellular calcium is also increased (d). These effects were found in human mononuclear leukocytes and are discussed in the text. is only 20 min. The authors point out that transepithelial processes may have a longer latency period which could be related to secondary, electrogenic processes. These changes could be de¬ tected only by electrophysiological means. The ac¬ tivation of the electroneutral sodium-proton exchanger as a possible primary target of the mineralocorticoid action is likely to be missed by these methods.
We therefore investigated the effects of aldosterone on the sodium-proton exchanger in H ML. By measuring the amiloride-sensitive swelling of HML in isotonic sodium propionate medium we found this transporter to be significantly stimulated, by 20-30%, as early as 3 min after incubation with the steroid. This action of aldosterone was highly sig¬ nificant up to 30 min at concentrations above 0.1 nmol/1. It could be antagonized by amiloride Cor¬ tisol was a partial agonist (50) .
Thus, the effects of aldosterone on electrolytes and cell volume in HML appear to be comparable to those initiated by the regulatory volume incre¬ ment: aldosterone either directly or indirectly (via the nucleus) stimulates the sodium/proton exchanger increasing the intracellular sodium con¬ centration. Thereby, Na-K-ATPase is activated and potassium exchanged for sodium. For 
